Pharm Test 3 Flashcards

1
Q

Distribution depends on: 5 things

A

BF, capillary permeability, protein binding, lipophilicity, tissue volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Plasma Compartment

A

(intravascular fluid), low Vd, 4% water weight, high mol weight drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Extracellular Compartment

A

(interstitial and plasma), high Vd, 20% water weight, low mol weight drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Volume of Distribution (eq)

A

Vd= dose [ ] / plasma drug [ ] (or total fluid drug [ ])

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Half life determines

A

dose frequency, elimination, length of effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clearance (eq)

A

CL= (.639 x Vd)/half life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

First Order Kinetics

A

constant proportion

- rate of drug elimination is proportional to drug [ ]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Zero Order Kinetics

A

constant rate

-rate of elimination is independent to drug [ ]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Biotranformations Phases 1 and 2

A
  • Goal is to become hydrophilic for excretion
    phase 1= adds polarized group (hydrolysis, oxidation by CYP 450 enzyme)
    phase 2= links to acid= inactive (conjugation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Urine Excreion=

A

filtration + secretion - reabsorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Steady State proportional to? and inversely to?

A
  • infusion

- clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Loading Dose (eq)

A

LD= Vd x Css (mg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Maintenance Dose (eq)

A

MD= CL x Css (mg/kg/hr)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Drug Approval Process (4 steps)

A

in vitro, animal testing, clinical testing, marketing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Clinical Trials (4 phases)

A
  • phase 1= small population, evaluate dose response
  • phase 2= evaluates efficacy, larger group, placebo, blind
  • phase 3= lots of population, comparison with other drugs, evaluate effects, placebo, blind
  • phase 4= post marketing surveillance, toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drug must have appropriate

A

size, electrical charge, shape, atomic composition

17
Q

Drug Electrical Charge (receptor bonds) - 3

A
  • covalent= irreversible
  • electrostatic= pos attract to neg
  • hydrophobic= weak (more selective)
18
Q

Major Receptor Families

A
  • ligand gated ion channels (sec)
  • g protein/cascade (min)
  • enzyme linked receptors: activates enzyme (hours)
  • intracellular receptors (days)= makes protein
19
Q

Spare Receptors

A

only a fraction of total receptors needed to elicit max response

20
Q

Protection from Excess Stimulation (3)

A
  • desensitization
  • down regulation
  • refractory period
21
Q

Potency vs Efficacy

A
P= amount of drug needed to produce given percent effect
E= magnitude of response a drug causes
22
Q

EC50

A

concentration producing 50% of max effect (potency)

23
Q

4 Laws of Drug Receptor

A

1- drug and receptor combine reversibly
2- occupied receptors proportional to # of drug and receptors
3- magnitude proportional to activated receptors
4- plateau effect because of limited # of receptors

24
Q

Agonist

A

Binds to receptor and makes response
1- full agonist- produce Emax
2- partial agonist- can’t produce Emax
3- inverse agonist- stabilized inactive form

25
Q

Antagonist

A

blocks response
1- competitive- enough agonist can overcome it (high potency)
2- noncompetitive- cannot be overcome by agonist (lower Emax)
a- irreversible- covalent bond can’t come off
b- allosteric- binds to different site and blocks activation
3- functional- different receptor and opposite effect
4- chemical- drug binds to agonist

26
Q

Quantal Dose-Response (ED50 and TD50)

A

measure safety

  • ED50- dose for therapeutic effect in 50% population
  • TD50- dose for toxic effect in 50% population
27
Q

Therapeutic Index (eq)

A

TI= (TD50)/(ED50)

needs to be above 2